Eloxx Pharmaceuticals Inc (ELOX)
0.8133
-0.04
(-4.31%)
USD |
OTCM |
May 09, 16:00
Eloxx Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | -10.28K% |
| September 30, 2015 | -482.0% |
| June 30, 2015 | -2.42K% |
| March 31, 2015 | -3.27K% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -1.78K% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -763.8% |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | -1.22K% |
| Date | Value |
|---|---|
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | -1.78K% |
| December 31, 2008 | |
| September 30, 2008 | -590.7% |
| June 30, 2008 | |
| March 31, 2008 | -2.58K% |
| December 31, 2007 | -20.71K% |
| September 30, 2007 | -102.9% |
| June 30, 2007 | -2.29K% |
| March 31, 2007 | -12.82K% |
| December 31, 2006 | -626.6% |
| September 30, 2006 | -739.0% |
| June 30, 2006 | -12.58K% |
| March 31, 2006 | -2.03K% |
| December 31, 2005 | -7.31K% |
| September 30, 2005 | -7.18K% |
| June 30, 2005 | -5.61K% |
| March 31, 2005 | -7.27K% |
| December 31, 2004 | -737.4% |
| September 30, 2004 | -5.79K% |
| June 30, 2004 | -8.89K% |
| March 31, 2004 | -10.01K% |
| December 31, 2003 | |
| September 30, 2003 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |